Advanced Stage Non-small Cell Lung Cancer
3 clinical trials · Condition
◉ Watch Advanced Stage Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs (NCT02350764) | Memorial Sloan Kettering Cancer Center | 2015-01-20 |
| Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc (NCT01955421) | Sun Yat-sen University | 2013-07-01 |
Track Advanced Stage Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.